Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus.
Miró JM, García-de-la-Mària C, Armero Y, de-Lazzari E, Soy D, Moreno A, del Rio A, Almela M, Mestres CA, Gatell JM, Jiménez-de-Anta MT, Marco F; Hospital Clínic Experimental Endocarditis Study Group.
Miró JM, et al. Among authors: marco f.
Antimicrob Agents Chemother. 2007 Jul;51(7):2373-7. doi: 10.1128/AAC.01266-06. Epub 2007 May 7.
Antimicrob Agents Chemother. 2007.
PMID: 17485502
Free PMC article.